← Back to catalogue

Sure-Screen®

FDA UDI

Class II (US FDA UDI)

by Medtox Diagnostics, Inc.

Identity

Trade Name
SURE-SCREEN® FDA UDI
Generic Name
Multiple drugs of abuse IVD, kit, rapid ICT, clinical FDA UDI
Device Name
A rapid screening test system for the detection of Amphetamine, Benzodiazepines, Cocaine, Opiates, and THC (Cannabinoids) drugs and/or their metabolites in human urine. FDA UDI
Model / Reference
600680 FDA UDI
Description
A rapid screening test system for the detection of Amphetamine, Benzodiazepines, Cocaine, Opiates, and THC (Cannabinoids) drugs and/or their metabolites in human urine. FDA UDI

Identifiers

Primary DI / UDI-DI
00690286000377 FDA UDI
510(k) Number
K050394 FDA UDI
FDA Product Code
JXM FDA UDI
DKZ FDA UDI
DJG FDA UDI
DIO FDA UDI
LDJ FDA UDI
GMDN Term
Multiple drugs of abuse IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3170 FDA UDI
862.3100 FDA UDI
862.3650 FDA UDI
862.3250 FDA UDI
862.3870 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Sure-Screen® by Medtox Diagnostics, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Cleared under the same submission

K050394 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Medtox Diagnostics, Inc.

Sources (1)

  • FDA UDI 87ce9375-89ed-4a8d-b12c-bafb7c69472c 37 fields · synced Jun 8, 2026